Neuland

NEULANDLAB.NS

Tags: IN Healthcare Drug Manufacturers - Specialty & Generic

Neuland Laboratories Price (NEULANDLAB.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

12,829,889

(0)%

Market Cap of Neuland (NEULANDLAB.NS)

Market cap:

As of , NEULANDLAB.NS has a market cap of . This makes NEULANDLAB.NS the 342th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $5540.1-18100
Market Cap 140.15B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Davuluri Sucheth Rao
IPO Date: October, 13, 2008
Country: IN
Currency: INR
Headquaters: No Data
Employees: 1643

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: